JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, F. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 107, Issue 2, 250-257, 1953
Copyright © 1953 by American Society for Pharmacology and Experimental Therapeutics


THE ANALEPTIC ACTION OF 1-n-BUTYLAMINO-3-p-TOLUIDINO-2-PROPANOL (W181) IN MEPHENESIN PARALYSIS

F. M. Berger 1

1 Wallace Laboratories, Inc., New Brunswick, New Jersey

1-n-Butylamino-3-p-toluidino-2-propanol, called W181, possesses convulsant activity in similar doses as picrotoxin. W181 differs from picrotoxin in producing convulsions of greater violence, in possessing an even narrower margin between convulsant and lethal doses and in not causing delayed convulsions.

W181 is the only known drug that can arouse animals from paralysis caused by mephenesin. W181 is however ineffective in saving the lives of animals which have received lethal doses of mephenesin.

W181 has a marked analeptic action in pentobarbital anesthesia and is in this respect only slightly inferior to picrotoxin. W181 is also effective, but very much less so than picrotoxin, in counteracting the effects of a lethal dose of pentobarbital.

W181 appears unsuitable for the production of therapeutic convulsions in humans because of the narrow margin between convulsant and lethal doses. It would also be inadvisable to use this potent and dangerous drug climcally after an overdose of mephenesin because spontaneous recovery is likely even after ingestion of very large doses of mephenesin.

Submitted on October 22, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1953 by the American Society for Pharmacology and Experimental Therapeutics.